Host antigen-presenting cell translation machinery

The host antigen-presenting cell (APC) translation machinery is the complex cellular system responsible for synthesizing proteins from mRNA within specialized immune cells like dendritic cells and macrophages (Sahin et al., 2014, Nat Rev Drug Discov). This machinery includes ribosomes, aminoacyl-tRNA synthetases, and various initiation and elongation factors that facilitate the decoding of genetic information into functional polypeptides (Pardi et al., 2018, Nat Rev Drug Discov). In the context of mRNA-based therapeutics and vaccines, this endogenous system is leveraged to produce specific viral or tumor-associated antigens directly within the host's immune system (Kranz et al., 2016, Nature). Following the delivery of synthetic mRNA into the APC cytoplasm, the host's translation apparatus processes the sequence to generate proteins that are subsequently presented on Major Histocompatibility Complex (MHC) molecules to prime T-cell responses (Iavarone et al., 2017, Expert Rev Vaccines). This approach bypasses the need for recombinant protein production and allows for a potent, multifaceted immune activation. However, the effectiveness of targeting this machinery depends heavily on the optimization of mRNA stability and the use of delivery vehicles that can bypass intracellular degradation pathways. Safety concerns include the potential for unintended innate immune activation through the sensing of exogenous RNA by Toll-like receptors. This machinery is the fundamental biological engine that enables the efficacy of modern mRNA vaccines against infectious diseases and emerging cancer immunotherapies.

Other names

Host cell translation apparatusAPC protein synthesis machineryRibosomal translation systemHost cell protein synthesis machinery

Translation of exogenous mRNA into antigenic proteins within host antigen-presenting cells to stimulate an immune response (Sahin et al., 2014, Nat Rev Drug Discov).